Per Texas Senate Bill no. 62, beginning January 1, 2012, all entering Texas college students, under the age of 22, must receive a vaccination or booster (if the vaccination is five years old) against bacterial meningitis before enrollment. Acceptable forms of the vaccination include Meningococcal Conjugate Vaccine (MenACWY), Meningococcal Conjugate Vaccines (MCV) or Meningococcal Polysaccharide Vaccine (MPSV4). The Texas Higher Education Coordinating Board (THECB) notes the vaccination with the MenB vaccine should not replace the vaccination with MENACWY. Therefore, it does not constitute as a replacement for the meningococcal conjugate vaccine (MenACWY) and does not fulfill the vaccination requirement.
Before you can register for classes you must submit together:
The target deadline to submit your proof of immunization is 2 weeks prior to your orientation date. Registration Deadlines: (Failure to receive the vaccination by the dates below will prevent you from enrolling for the term.) The 2020 spring term vaccination deadline is January 3, 2020. The 2019 fall term vaccination deadline was August 9, 2019. The 2019 summer term vaccination deadline was May 13, 2019. * The vaccination must be less than five years old (on the first day of class).
Documentation must be in English, state the name and other information sufficient to identify the individual who received the required vaccination, state the month, date and year the vaccine was administered.
To submit the requirement form and supporting documents, follow the instructions below:
The other option is to mail it to the following address:
The University of Texas at Dallas The Office of the Registrar, SSB13 800 West Campbell Rd Richardson, TX 75080-3021
Bacterial Meningitis is a serious, potentially deadly disease that can progress extremely fast. It is an inflammation of the membranes that surround the brain and spinal cord. The bacterium that causes meningitis can also infect the blood. For more information, please review “What You Need to Know About Meningitis" (PDF).
Questions? Email: [email protected]